CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-16 | Floroiu Cezar Andrei President, Chief Exec Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2021-06-11 | Yedid Robert A. Director | Option exercise | +18,240 | $0.31 | $6K | 18,240 |
| 2021-06-11 | Yedid Robert A. Director | Sale | −10,000 | $8.61 | $86K | 8,240 |
| 2021-06-11 | Yedid Robert A. Director | Option exercise · Stock Option (right to buy) | −18,240 | 36,480 | ||
| 2021-06-11 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise | +334 | $5.17 | $2K | 334 |
| 2021-06-11 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise | +1,468 | $0.77 | $1K | 1,802 |
| 2021-06-11 | Echerd Margaret SVP, Principal Accntng Officer | Sale | −1,802 | $8.00 | $14K | 0 |
| 2021-06-11 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise · Stock Option (right to buy) | −334 | 3,333 | ||
| 2021-06-11 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise · Stock Option (right to buy) | −1,468 | 33,754 | ||
| 2021-06-09 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise | +12,333 | $5.17 | $64K | 12,333 |
| 2021-06-09 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise | +35,222 | $0.77 | $27K | 47,555 |
| 2021-06-09 | Echerd Margaret SVP, Principal Accntng Officer | Sale | −47,555 | $8.00 | $380K | 0 |
| 2021-06-09 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise · Stock Option (right to buy) | −12,333 | 3,667 | ||
| 2021-06-09 | Echerd Margaret SVP, Principal Accntng Officer | Option exercise · Stock Option (right to buy) | −35,222 | 35,222 | ||
| 2021-05-07 | Latour Wouter Director | Option exercise | +100,000 | $1.70 | $170K | 100,000 |
| 2021-05-07 | Latour Wouter Director | Sale | −100,000 | $7.13 | $713K | 0 |
| 2021-05-07 | Latour Wouter Director | Option exercise · Stock Option (right to buy) | −100,000 | 700,000 | ||
| 2021-05-06 | Latour Wouter Director | Option exercise | +100,000 | $1.70 | $170K | 100,000 |
| 2021-05-06 | Latour Wouter Director | Sale | −100,000 | $6.54 | $654K | 0 |
| 2021-05-06 | Latour Wouter Director | Option exercise · Stock Option (right to buy) | −100,000 | 800,000 |
Page 13 of 23 · 442 trades